Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Graft-Versus-Host Disease after Anti-CD19 Chimeric Antigen Receptor T-Cell Infusion Post Allogeneic Hematopoietic Cell Transplantation: A Transplant Complications and Paediatric Disease Working Parties EBMT Joint Study

Blood (2023) 142 (Supplement 1): 2189.

https://doi.org/10.1182/blood-2023-177715

Published: 2023

Journal Articles

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Blood (2022) 140 (Supplement 1): 12938–12940.

https://doi.org/10.1182/blood-2022-162484

Published: 2022

Journal Articles

Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study

Blood (2022) 140 (Supplement 1): 4718–4720.

https://doi.org/10.1182/blood-2022-164538

Published: 2022

Journal Articles

Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network

Jakob D. Rudzki, Ulrich Jaeger, Dominik Wolf, Andreas Petzer, Richard Greil, Christina Peters, Hildegard T. Greinix, Andishe Attarbaschi, Veronika Buxhofer-Ausch, Michael Girschikofsky, Wolfgang Holter, Michael Leisch, Peter Neumeister, Peter Schlenke, Clemens A. Schmitt, Wolfgang Schwinger, Nina Worel, Philipp Wohlfarth

Blood (2022) 140 (Supplement 1): 6661–6663.

https://doi.org/10.1182/blood-2022-167603

Published: 2022

Journal Articles

Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation

Blood (2018) 132 (Supplement 1): 646.

https://doi.org/10.1182/blood-2018-99-115399

Published: 2018

Journal Articles

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Blood (2018) 132 (Supplement 1): 486.

https://doi.org/10.1182/blood-2018-99-114033

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Hypomorphic mutation in TTC7A causes combined immunodeficiency with mild structural intestinal defects

Stavroula Woutsas, Caner Aytekin, Elisabeth Salzer, Cecilia Domínguez Conde, Sema Apaydin, Herbert Pichler, Nima Memaran-Dadgar, Ferda Ozbay Hosnut, Elisabeth Förster-Waldl, Susanne Matthes, Wolf-Dietrich Huber, Thomas Lion, Wolfgang Holter, Ivan Bilic, Kaan Boztug

Blood (2015) 125 (10): 1674–1676.

https://doi.org/10.1182/blood-2014-08-595397

Published: 2015

Includes: Supplemental data

Journal Articles

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ

Elisabeth Salzer, Elisangela Santos-Valente, Stefanie Klaver, Sol A. Ban, Wolfgang Emminger, Nina Kathrin Prengemann, Wojciech Garncarz, Leonhard Müllauer, Renate Kain, Heidrun Boztug, Andreas Heitger, Klaus Arbeiter, Franz Eitelberger, Markus G. Seidel, Wolfgang Holter, Arnold Pollak, Winfried F. Pickl, Elisabeth Förster-Waldl, Kaan Boztug

Blood (2013) 121 (16): 3112–3116.

https://doi.org/10.1182/blood-2012-10-460741

Published: 2013

Includes: Supplemental data

Journal Articles

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger, Andre M. Willasch, Hermann Kreyenberg, Arndt Borkhardt, Wolfgang Holter, Bernhard Kremens, Brigitte Strahm, Wilhelm Woessmann, Christine Mauz-Koerholz, Bernd Gruhn, Stefan Burdach, Michael H. Albert, Paul-Gerhardt Schlegel, Thomas Klingebiel, Peter Bader

Blood (2011) 118 (20): 5681–5688.

https://doi.org/10.1182/blood-2011-04-348805

Published: 2011

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Blood (2010) 116 (21): 530.

https://doi.org/10.1182/blood.V116.21.530.530

Published: 2010

Journal Articles

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Daniel Stachel, MD, Nora Naumann-Bartsch, MD, Patrick Morhart, MD, Markus Metzler, MD, Thorsten Langer, MD, Klaus Schwarz, Wolfgang Holter, MD

Blood (2010) 116 (21): 4696.

https://doi.org/10.1182/blood.V116.21.4696.4696

Published: 2010

Journal Articles

Significant Reduction of Treatment Related Mortality after Stem Cell Transplantation in 647 Children and Adolescents with ALL within BFM Trials during the Last 12 Years: A Long Term Analysis from 1996 to 2007

André Schrauder, Martin Schrappe, Arend Stackelberg, Peter Bader, Wolfgang Holter, Rupert Handgretinger, Wolfram Ebell, Dagmar Dilloo, Tayfun Güngör, Monika Fuehrer, Hartmut Kabisch, Martin Zimmermann, Ulrike Poetschger, Karl-Walter Sykora, Christina Peters

Blood (2008) 112 (11): 567.

https://doi.org/10.1182/blood.V112.11.567.567

Published: 2008

Journal Articles

The Importance of Harmonizing Transplantation Procedures in Children with ALL: ALL-SCT-BFM 2003, a Prospective Multicenter Trial.

André Schrauder, MD, Arend Stackelberg, MD, Martin Schrappe, MD, Thomas Klingebiel, MD, Wolfgang Holter, MD, Karl-Walter Sykora, MD, Rupert Handgretinger, MD, Wolfram Ebell, MD, Ulrike Pötschger, PhD, Martin Zimmermann, PhD, Susanne Karlhuber, PhD, Christina Peters, MD

Blood (2007) 110 (11): 1099.

https://doi.org/10.1182/blood.V110.11.1099.1099

Published: 2007

Journal Articles

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Roland Meisel, MD, Lisa Kuypers, Bernd Gruhn, MD, Gabi Strauss, MD, Brigitte Strahm, MD, Karoline Ehlert, MD, Karin Beutel, MD, Wolfgang Holter, MD, Renate Bluetters-Sawatzki, MD, Tobias Feuchtinger, MD, Hans-Peter Gruettner, MD, Ralf Schubert, PhD, Sabine Diedrich, MD, Marion Riffelmann, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2007) 110 (11): 164.

https://doi.org/10.1182/blood.V110.11.164.164

Published: 2007

Journal Articles

Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

Roland Meisel, Lisa Kuypers, Uta Dirksen, Ralf Schubert, Bernd Gruhn, Gabriele Strauss, Karin Beutel, Andreas H. Groll, Ulrich Duffner, Renate Blütters-Sawatzki, Wolfgang Holter, Tobias Feuchtinger, Hans-Peter Grüttner, Horst Schroten, Stefan Zielen, Christian Ohmann, Hans-Jürgen Laws, Dagmar Dilloo, for the Impfung von Kindern nach allogener Stammzelltransplantation (IKAST) Study Group

Blood (2006) 109 (6): 2322–2326.

https://doi.org/10.1182/blood-2006-06-032284

Published: 2006

Journal Articles

Vaccination with the Heptavalent Pneumococcal Conjugate Vaccine Prevenar™ Provides Early Protective Antibody Responses in Children after Allogeneic Stem Cell Transplantation.

Roland Meisel, MD, Uta Dirksen, MD, Ralf Schubert, PhD, Bernd Gruhn, MD, Gabriele Strauss, MD, Ulrich Duffner, MD, Andreas Groll, MD, Karin Beutel, MD, Renate Bluetters-Sawatzki, MD, Wolfgang Holter, MD, Tobias Feuchtinger, MD, Hans-Peter Gruettner, MD, Stefan Zielen, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2005) 106 (11): 84.

https://doi.org/10.1182/blood.V106.11.84.84

Published: 2005

Journal Articles

Control of Fulminant Juvenile Myelomonocytic Leukemia (JMML) Relapse and Gut GvHD III° with Purinethol Early after Unrelated Donor BMT.

Daniel Stachel, M.D., Chara Gravou-Apostolatou, M.D., Michaela Kuhlen, M.D., Alfred Leipold, M.D., Peter Bader, M.D., Jorn Beck, M.D., Wolfgang Holter, M.D.

Blood (2004) 104 (11): 5089.

https://doi.org/10.1182/blood.V104.11.5089.5089

Published: 2004

Journal Articles

Defective T-helper cell function after T-cell–depleting therapy affecting naive and memory populations

Andreas Heitger, Patricia Winklehner, Petra Obexer, Johannes Eder, Claudia Zelle-Rieser, Gabriele Kropshofer, Martin Thurnher, Wolfgang Holter

Blood (2002) 99 (11): 4053–4062.

https://doi.org/10.1182/blood.V99.11.4053

Published: 2002

NARROW

Graft-Versus-Host Disease after Anti-CD19 Chimeric Antigen Receptor T-Cell Infusion Post Allogeneic Hematopoietic Cell Transplantation: A Transplant Complications and Paediatric Disease Working Parties EBMT Joint Study

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study

Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network

Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Hypomorphic mutation in TTC7A causes combined immunodeficiency with mild structural intestinal defects

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

TBI Based Conditioning Regimen and Intra Osseous Application of PBSC to Overcome Graft Resistance In a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS)

Significant Reduction of Treatment Related Mortality after Stem Cell Transplantation in 647 Children and Adolescents with ALL within BFM Trials during the Last 12 Years: A Long Term Analysis from 1996 to 2007

The Importance of Harmonizing Transplantation Procedures in Children with ALL: ALL-SCT-BFM 2003, a Prospective Multicenter Trial.

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

Vaccination with the Heptavalent Pneumococcal Conjugate Vaccine Prevenar™ Provides Early Protective Antibody Responses in Children after Allogeneic Stem Cell Transplantation.

Control of Fulminant Juvenile Myelomonocytic Leukemia (JMML) Relapse and Gut GvHD III° with Purinethol Early after Unrelated Donor BMT.

Defective T-helper cell function after T-cell–depleting therapy affecting naive and memory populations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only